Oculis to Speak at BofA Global Healthcare Conference

May 06, 2024 - Oculis Holding AG (Nasdaq: OCS; XICE: OCS), a global biopharmaceutical company dedicated to advancing eye care and preserving vision, announced today that its management team will be participating in the Bank of America Healthcare Conference scheduled for May 14-16, 2024, in Las Vegas, NV.

Dr. Riad Sherif, the Chief Executive Officer of Oculis, is set to present on behalf of the company on Wednesday, May 15th, at 11:20 am PT at the Encore Hotel. The presentation will also be accessible via a live webcast. Additionally, the company will be available for individual meetings throughout the conference. Investors interested in scheduling a meeting should contact their Bank of America representative. A link to access the company's presentation, once it becomes available, will be posted on Oculis' website under the Events & Presentation page in the Investors & Media section.

Oculis is recognized globally for its innovative approach to eye care. The company is actively developing a diverse pipeline of unique product candidates aimed at treating various eye conditions. Among its leading candidates is OCS-01, a topical eye drop designed for diabetic macular edema (DME) and for mitigating inflammation and pain after cataract surgery. Another notable candidate is OCS-02, a topical biologic anti-TNFα eye drop intended for dry eye disease (DED) and non-infectious anterior uveitis. Additionally, Oculis is working on OCS-05, a candidate aimed at modifying the course of acute optic neuritis (AON).

Oculis is headquartered in Switzerland, with significant operations in the United States and Iceland. The company's mission is to enhance the health and quality of life of patients on a global scale. It is driven by a skilled management team with a proven track record of success and backed by prominent international healthcare investors.

How to obtain the latest research advancements in the field of biopharmaceuticals?

In the Synapse database, you can keep abreast of the latest research and development advances in drugs, targets, indications, organizations, etc., anywhere and anytime, on a daily or weekly basis. Click on the image below to embark on a brand new journey of drug discovery!